Lower risk of atrial fibrillation development associated with SGLT-2 inhibitors in type 2 diabetic patients compared to DPP-4 inhibitors: a nationwide cohort study
Event:
ESC Congress 2023
Topic:
Prevention
Session:
Remodelling, prognosis, and outcomes in atrial fibrillation
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
